ATE342735T1 - Orale pharmazeutische zusammensetzungen mit reduzierter bitterkeit durch geschmacksmaskiermittel - Google Patents

Orale pharmazeutische zusammensetzungen mit reduzierter bitterkeit durch geschmacksmaskiermittel

Info

Publication number
ATE342735T1
ATE342735T1 AT98911029T AT98911029T ATE342735T1 AT E342735 T1 ATE342735 T1 AT E342735T1 AT 98911029 T AT98911029 T AT 98911029T AT 98911029 T AT98911029 T AT 98911029T AT E342735 T1 ATE342735 T1 AT E342735T1
Authority
AT
Austria
Prior art keywords
scammers
flavor
pharmaceutical compositions
oral pharmaceutical
reduced bitterness
Prior art date
Application number
AT98911029T
Other languages
English (en)
Inventor
Koji Ukai
Tsutomu Harada
Yasuyuki Suzuki
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE342735T1 publication Critical patent/ATE342735T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98911029T 1997-03-28 1998-03-26 Orale pharmazeutische zusammensetzungen mit reduzierter bitterkeit durch geschmacksmaskiermittel ATE342735T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7856897 1997-03-28
JP34326597 1997-12-12

Publications (1)

Publication Number Publication Date
ATE342735T1 true ATE342735T1 (de) 2006-11-15

Family

ID=26419628

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98911029T ATE342735T1 (de) 1997-03-28 1998-03-26 Orale pharmazeutische zusammensetzungen mit reduzierter bitterkeit durch geschmacksmaskiermittel

Country Status (9)

Country Link
US (1) US7727552B1 (de)
EP (1) EP0974366B1 (de)
JP (1) JP5053228B2 (de)
KR (1) KR100693266B1 (de)
AT (1) ATE342735T1 (de)
DE (1) DE69836207T2 (de)
DK (1) DK0974366T3 (de)
ES (1) ES2273409T3 (de)
WO (1) WO1998043675A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1025858A4 (de) * 1998-08-28 2009-03-11 Eisai R&D Man Co Ltd Arzneimittel mit verminderter bitterkeit usw.
KR20000046974A (ko) * 1998-12-31 2000-07-25 윤재승 아세글루타미드 알루미늄의 경구 투여용 제제 조성물ㅇ
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
AU2002225763A1 (en) 2000-11-28 2002-06-11 Fmc Corporation Edible pga(propylene glycol alginate) coating composition
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
AU2256702A (en) * 2000-12-01 2002-06-11 Kyowa Hakko Kogyo Kk Composition improved in solubility or oral absorbability
TW200306868A (en) * 2002-05-22 2003-12-01 Shionogi & Co Composition of hardly soluble medicine with improved solubility
CA2552221A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Donepezil formulations
EP2222311B1 (de) 2007-12-20 2013-03-27 N.V. Nutricia Flüssiges nucleotide/nucleoside enthaltendes produkt
US20110124577A1 (en) * 2008-07-30 2011-05-26 Suntory Holdings Limited Preparation for oral administration comprises quercetin glycoside and a water-based solvent extract of cartilage containing chondroitin sulfate
US8715715B2 (en) 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
PL2243473T3 (pl) 2009-04-17 2019-01-31 Hexal Ag Tabletki zawierające środek maskujący smak
EP2366378A1 (de) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Donepezilformulierungen mit verzögerter Freisetzung
JP5491943B2 (ja) * 2010-04-28 2014-05-14 ゼリア新薬工業株式会社 ビタミンｂ１類含有経口ゼリー剤
SG188509A1 (en) 2010-09-13 2013-04-30 Bev Rx Inc Aqueous drug delivery system comprising off - flavor masking agent
EP2468254A1 (de) 2010-12-15 2012-06-27 Hexal AG Oral zerfallende Tablette mit Geschmacksunterdrückungseffekt
WO2012087324A1 (en) * 2010-12-23 2012-06-28 Colgate-Palmolive Company Fluid oral care compositions
EP2911530B1 (de) * 2012-10-25 2017-02-01 Nestec S.A. Eingekapselte bittere peptide, verfahren zum einkapseln bittere peptide und nahrungszusammensetzungen mit verkapselten bitteren peptiden
CA2921308A1 (en) 2013-08-16 2015-02-19 Universiteit Maastricht Treatment of cognitive impairment with pde4 inhibitor
CN106727272A (zh) * 2016-12-08 2017-05-31 星康桥医药科技（南京）有限公司 一种漱口制剂及漱口方法
CN110167551B (zh) 2016-12-28 2022-06-14 富士胶片富山化学株式会社 医药组合物
KR20200064951A (ko) 2018-11-29 2020-06-08 동국제약 주식회사 약리학적 활성 성분을 함유한 구강붕해필름 및 그의 제조방법
IL303952A (en) 2021-01-28 2023-08-01 Galvita Ag Solid pharmaceutical preparation and methods for its preparation
EP4311543A1 (de) 2022-07-27 2024-01-31 Galvita AG Verfahren zum laden von invertierten vorlagenträgern

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5176413A (ja) 1974-12-25 1976-07-02 Toyo Jozo Kk Hifukuzainoseizoho
JPS5476818A (en) 1977-11-25 1979-06-19 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition having prolonged effect and production thereof
JPS5565741A (en) * 1978-11-10 1980-05-17 Tokico Ltd Shock absorber
GB2122892B (en) 1982-07-02 1986-01-29 Squibb & Sons Inc Nystantin pastille formulation
JPS60204712A (ja) 1984-03-29 1985-10-16 Ss Pharmaceut Co Ltd 塩酸メクリジンの安定化液状組成物
JPS61130239A (ja) 1984-11-30 1986-06-18 Dai Ichi Seiyaku Co Ltd 複合体
US5286489A (en) * 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
JPS63309150A (ja) * 1987-06-11 1988-12-16 San Ei Chem Ind Ltd 即席ゲル状物の製造法
JPH0717498B2 (ja) 1989-05-31 1995-03-01 興和株式会社 鎮咳去痰ソフトカプセル剤
US5084278A (en) 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5013557A (en) 1989-10-03 1991-05-07 Warner-Lambert Company Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
US5077053A (en) 1990-02-12 1991-12-31 Warner-Lambert Company Zein as a moisture barrier for sugarless edible compositions and method for preparing same
JPH03287535A (ja) 1990-03-31 1991-12-18 Bairon Boeki Kk プラノプロフェン水溶液
JPH0418015A (ja) 1990-05-10 1992-01-22 Fujikawa Kk 安定なフマル酸クレマスチン水溶液
JP2508547B2 (ja) * 1991-01-08 1996-06-19 株式会社紀文食品 苦味低減方法及び苦味低減化組成物
JP3073544B2 (ja) 1991-02-18 2000-08-07 三栄源エフ・エフ・アイ株式会社 塩化カリウムの脱苦味方法
JPH04282312A (ja) 1991-03-08 1992-10-07 Eisai Co Ltd コ−ティング層を有する粒状物
JP2508555B2 (ja) 1991-05-24 1996-06-19 株式会社紀文食品 苦味低減方法
CA2068402C (en) 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
DE4122217C2 (de) 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
JPH05163154A (ja) 1991-12-13 1993-06-29 Kanebo Ltd 経口液剤
NZ246091A (en) 1991-12-24 1995-08-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation containing an active ingredient, agar, and lactose and/or mannitol
ATE216577T1 (de) 1992-01-29 2002-05-15 Takeda Chemical Industries Ltd Schnellösliche tablette und ihre herstellung
JPH06218028A (ja) 1992-10-02 1994-08-09 Eisai Co Ltd 湿製錠の成型方法とその装置及び湿製錠
WO1994013257A1 (en) 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
ATE181672T1 (de) * 1993-04-28 1999-07-15 Takeda Chemical Industries Ltd Geschmacksmaskierte feste zubereitung und verfahren zur herstellung
WO1995009895A1 (en) 1993-10-01 1995-04-13 Kao Corporation Ultraviolet shielding composite fine particles, method for producing the same, and cosmetics
US5576014A (en) 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
JPH07267850A (ja) 1994-03-28 1995-10-17 Eisai Co Ltd 不快味を防止した医薬組成物及びその製造方法
US5672364A (en) 1994-07-07 1997-09-30 Sankyo Seisakusho Co. & Eisai Co., Ltd. Apparatus for manufacturing tablets
JP3187657B2 (ja) 1994-07-08 2001-07-11 株式会社三共製作所 錠剤製造方法およびその装置
DE4432757A1 (de) 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
US5656284A (en) * 1995-04-24 1997-08-12 Balkin; Michael S. Oral transmucosal delivery tablet and method of making it
JPH08333245A (ja) 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
IN182040B (de) 1995-06-13 1998-12-12 American Home Prod
TW442287B (en) 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
JPH0948726A (ja) 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
JPH09143100A (ja) 1995-11-20 1997-06-03 Sumitomo Pharmaceut Co Ltd 服用感の改善された固形製剤
US6214386B1 (en) 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
US5612026A (en) * 1996-01-25 1997-03-18 The Procter & Gamble Company Cholesterol lowering drink mix compositons
JPH103629A (ja) 1996-06-14 1998-01-06 Asahi Komagu Kk 薄膜磁気ヘッドスライダーの製造方法
DE69738829D1 (de) 1996-07-12 2008-08-21 Daiichi Seiyaku Co Schnell zerfallende, druckgeformte Materialien sowie Prozess zu deren Herstellung
US5763449A (en) 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
JPH10114683A (ja) 1996-10-11 1998-05-06 Kobayashi Seiyaku Kogyo Kk 非ステロイド性解熱鎮痛消炎剤を含む固形製剤及びその製造方法
US5962535A (en) 1997-01-17 1999-10-05 Takeda Chemical Industries, Ltd. Composition for alzheimer's disease
JP3770518B2 (ja) 1997-03-28 2006-04-26 エーザイ株式会社 苦味等を隠蔽した経口薬剤
JP4234666B2 (ja) 1997-03-28 2009-03-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 苦味等を隠蔽した経口薬剤
TW580397B (en) 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
JP3797764B2 (ja) 1997-10-01 2006-07-19 エーザイ株式会社 光安定化組成物
TW527195B (en) 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
JPH11199517A (ja) 1997-10-31 1999-07-27 Meiji Seika Kaisha Ltd 口腔内速崩壊性錠剤
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
EP1025858A4 (de) 1998-08-28 2009-03-11 Eisai R&D Man Co Ltd Arzneimittel mit verminderter bitterkeit usw.
CA2346350C (en) 1998-10-05 2008-01-08 Eisai Co., Ltd. Intraoral quickly disintegrating tablets
AU1453600A (en) 1998-11-04 2000-05-22 Mcneil-Ppc, Inc. Solid oral dosage forms containing alginic acid and famotidine
US6656492B2 (en) 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof
ITMI20020686A1 (it) 2002-04-03 2003-10-03 Sitma Spa Dispositivo di stiro di una pellicola in una macchina confezionatriceautomatica di prodotti

Also Published As

Publication number Publication date
EP0974366A4 (de) 2003-03-26
EP0974366B1 (de) 2006-10-18
US7727552B1 (en) 2010-06-01
JP2009051855A (ja) 2009-03-12
EP0974366A1 (de) 2000-01-26
DK0974366T3 (da) 2007-01-29
DE69836207D1 (de) 2006-11-30
ES2273409T3 (es) 2007-05-01
WO1998043675A1 (en) 1998-10-08
JP5053228B2 (ja) 2012-10-17
KR20010005510A (ko) 2001-01-15
DE69836207T2 (de) 2007-08-30
KR100693266B1 (ko) 2007-03-27

Similar Documents

Publication Publication Date Title
ATE342735T1 (de) Orale pharmazeutische zusammensetzungen mit reduzierter bitterkeit durch geschmacksmaskiermittel
ATE209518T1 (de) Arzneipulverkartusche mit integrierter dosiereinrichtung, sowie pulverinhalator
DE69427472D1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
DE59309858D1 (de) Geschmacksmaskierte pharmazeutische Mittel
DE69606028D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
FI971986A7 (fi) Farmaseuttisia nanosuspensioita lääkeaineen antamiseen systeemeinä, joissa on kasvanut kyllästysliukoisuus ja liukenemisnopeus
EP0841932A4 (de) Verbesserte drogenverabreichung durch modifizierte saponine
DZ2887A1 (fr) Dérivés d'azétidine, leur préparation et les médicaments les contenant.
ATE109145T1 (de) Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3580616D1 (de) Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
FI943570A0 (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
IT8822379A0 (it) Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon.
DE69832816D1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
MX9204925A (es) Surtidor de medicamento en forma de polvo seco.
DE3879111D1 (de) Pharmazeutische kautablette mit geschmaksmaskierung.
ATE193533T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
FR2675802B1 (fr) Antiserotonines, leur preparation et les medicaments les contenant.
DE68901859D1 (de) 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung.
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
DE69217020D1 (de) Arzneimittel mit gesteuerter Wirkstoffabgabe
DE58904595D1 (de) Neue alkylphosphonoserine, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel.
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0974366

Country of ref document: EP

EEIH Change in the person of patent owner